Stock Price: 4.53
Review: Slight Profit. On a large drawdown due to biotech sector tanking across the industry. Many insider purchasing, probably might still be able to profit even iI held on to the stock.
May need to relook at biotech put valuation. The only one out of the 4 biotech companies left for Jul expiration that i could get out at a profit.